University of Montana

ScholarWorks at University of Montana
Integrative Physiology and Athletic Training
Faculty Publications

Integrative Physiology and Athletic Training

5-2012

Substrate Use and Biochemical Response to a 3,211-km Bicycle
Tour in Trained Cyclists
Dustin R. Slivka
University of Nebraska at Omaha

Charles Dumke
University of Montana - Missoula, charles.dumke@umontana.edu

Walter S. Hailes
University of Montana - Missoula

John S. Cuddy
University of Montana - Missoula

Brent Ruby
University of Montana - Missoula, brent.ruby@umontana.edu

Follow this and additional works at: https://scholarworks.umt.edu/hhp_pubs
Part of the Medicine and Health Sciences Commons

Let us know how access to this document benefits you.
Recommended Citation
Slivka, Dustin R.; Dumke, Charles; Hailes, Walter S.; Cuddy, John S.; and Ruby, Brent, "Substrate Use and
Biochemical Response to a 3,211-km Bicycle Tour in Trained Cyclists" (2012). Integrative Physiology and
Athletic Training Faculty Publications. 14.
https://scholarworks.umt.edu/hhp_pubs/14

This Article is brought to you for free and open access by the Integrative Physiology and Athletic Training at
ScholarWorks at University of Montana. It has been accepted for inclusion in Integrative Physiology and Athletic
Training Faculty Publications by an authorized administrator of ScholarWorks at University of Montana. For more
information, please contact scholarworks@mso.umt.edu.

Eur J Appl Physiol (2012) 112:1621–1630
DOI 10.1007/s00421-011-2129-3

ORIGINAL ARTICLE

Substrate use and biochemical response to a 3,211-km bicycle tour
in trained cyclists
Dustin R. Slivka • Charles L. Dumke •
Walter S. Hailes • John S. Cuddy • Brent C. Ruby

Received: 11 February 2011 / Accepted: 12 August 2011 / Published online: 25 August 2011
Ó Springer-Verlag 2011

Abstract The purpose of this study was to assess the
physiological adaptations in physically fit individuals to a
period of intensified training. Ten trained males cycled
outdoors *170 km day-1 on 19 out of 21 days. Expired
gas was collected on days 1 and 21 during maximal graded
exercise and used for the determination of gross efficiency
and whole body substrate use. Muscle biopsies were
obtained before and after exercise on days 2 and 22 for the
determination of mtDNA/gDNA ratio, gene expression,
metabolic enzyme activity and glycogen use. Muscle glycogen before and after exercise, fat oxidation, and gross
efficiency increased, carbohydrate oxidation decreased
(p \ 0.05), and VO2max did not change over the 21 days of
training. Citrate synthase (CS), b-hydroxyacyl CoA dehydrogenase (b-HAD) and cytochrome c oxidase (COX)
enzyme activity did not change with training. CS and
b-HAD mRNA did not change with acute exercise or
training. COX (subunit IV) mRNA increased with acute
exercise (p \ 0.05) but did not change over the 21 days.
PGC-1a mRNA increased with acute exercise, but did not
increase to the same degree on day 22 as it did on day 2
(p \ 0.05). UCP3 mRNA decreased with training
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(p \ 0.05). Acute exercise caused an increase in mitofusin2 (MFN2) mRNA (p \ 0.05) and a trend for an increase
in mtDNA/gDNA ratio (p = 0.057). However, training did
not affect MFN2 mRNA or mtDNA/gDNA ratio. In
response to 3,211 km of cycling, changes in substrate use
and gross efficiency appear to be more profound than
mitochondrial adaptations in trained individuals.
Keywords MtDNA  Cycling  Efficiency  Training
adaptation  Gene expression  Metabolic enzymes

Introduction
Endurance exercise training results in greater fatty acid
oxidation and less carbohydrate oxidation for a given
absolute workload (Hermansen et al. 1967; Hurley et al.
1984, 1986). Many of these adaptations can occur within
the first 5–12 days of endurance training (Cadefau et al.
1994; Chesley et al. 1996; Phillips et al. 1996). Traditionally, the ability of trained individuals to oxidize greater
amounts of fat is accounted for by increases in maximal
activity of mitochondrial enzymes (Holloszy 1967). However, many of the changes in substrate use and metabolites
have been observed without increased mitochondrial
function as measured by maximal activity of mitochondrial
enzymes (Phillips et al. 1996). Previous studies have
demonstrated a parallel increase in oxidative enzymes and
whole body substrate oxidation (Holloszy 1975), but lack a
causal link.
The exact measure of mitochondrial function that best
illustrates the oxidative potential of tissues remains elusive.
Maximal oxidative enzyme capacities (Chesley et al. 1996;
Phillips et al. 1996), balance of fission and fusion (Bach
et al. 2003), cardiolipin content (Claypool 2009), and
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mitochondrial DNA (mtDNA) to genomic DNA ratios
(Menshikova et al. 2005) have all been used to illustrate
oxidative potential of muscle. Further complicating the
time course of metabolic versus mitochondrial adaptation
is the recent advances in mitochondrial morphology, where
mitochondrion function is dictated by its state of fission
and/or fusion as opposed to number or density (Bach et al.
2003). The lack of a ‘‘gold standard’’ measurement of
mitochondrial function and the multiple aspects of mitochondrial function leaves this area of research complex and
the interpretation of previous research difficult. The use of
a multi-factorial approach to mitochondrial measurement
(including enzyme function, relative mtDNA copy number
and gene expression) may allow for a more complete,
methodology-independent, understanding of mitochondrial
adaptation. Specifically, we analyzed gene expression and
enzymatic activities of the beta-oxidation marker b-hydroxyacyl CoA dehydrogenase (b-HAD), the Krebs cycle
marker citrate synthase (CS), the electron transport
chain marker cytochrome C oxidase, subunit IV (COX).
Mitofusin2 (MFN2) was analyzed to address mitochondrial
fission (Bach et al. 2003). Peroxisome-proliferator-activated receptor-gamma co-activator 1 alpha (PGC-1a) and
uncoupling protein 3 (UCP3) were used as a marker for
mitochondrial development and substrate use (Bezaire
et al. 2007; Himms-Hagen and Harper 2001; Lin et al.
2004; Pilegaard et al. 2003; Wang et al. 2003; Wende et al.
2007). In order to address mitochondrial number the ratio
of mitochondrial to genomic DNA (Menshikova et al.
2007) was analyzed. Additionally, Whole body fat and
carbohydrate oxidation and local glycogen use were
included based on the relationship between mitochondrial
development and substrate use (Holloszy 1975). This
approach is not all inclusive; nonetheless, it offers a unique
approach to address the multiple mechanisms associated
with mitochondrial function.
The purpose of this study was to implement a period of
intensified training in physically fit individuals to access
the physiological adaptations with special attention to
mitochondrial and substrate use alterations. Since the
mitochondria plays an important role in determining substrate use, we hypothesized that substrate use would change
in parallel to mitochondrial function when using a multifactorial approach to mitochondrial measurement. Due to
the training status of the individuals and the training
stimulus that would be required to overload and induce
mitochondrial changes in these trained individuals, a laboratory model was not feasible. Participant adherence to a
lab-based protocol with the high training volume used in
this investigation would have been low. Therefore, in order
to provide an environment in which participants could
withstand the training load and to increase application/
external validity, this investigation was completed in the
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field and was organized as a training camp/cycling tour in
the western USA.

Materials and methods
Subjects
Ten (n = 10) male participants (24 ± 2 years of age,
181 ± 5 cm height) were recruited from the local triathlon
and cycling community. These individuals were recruited
due to their success in local endurance racing events and
thus having a realistic chance of completing the protocols
involved with the current investigation. Laboratory measures such as VO2max were not used as part of the inclusion
criteria as these measures may not be the best to access
capacity to withstand the high exercise volume involved
with the completion of the current protocol. The participants engaged in aerobic training for an average of
9.0 ± 5.0 h week-1 for the prior 4 weeks; however, no
specific criteria were set for training volume or years
practiced. Before any testing, participants read and signed
an informed consent form approved by the institutional
review board for the ethical use of human subject research.
Training, living conditions, nutrition, and stresses
All laboratory testing was completed in the same location
before and after training. See timeline in Fig. 1. Day 2 and
day 22 of cycling were completed on the same outdoor
terrain (169 km) and at the same time of the day (starting at
8:00 am) and without exercise within (20 h). Average ride
temperature during day 2 was slightly warmer (26 vs.
19°C), less humid (31 vs. 43% RH), but with similar wind
speeds (\2.24 m s-1) than day 22. The period of intensified training was organized as a bicycle tour through the
mountains of western USA. Participants cycled at a selfselected power output for the bulk of the training time
(except for scheduled performance trials and testing).
Training consisted of cycling approximately 170 km day-1
on 19 of the 22 days. Days 1 and 21 were scheduled as max
test days (only maximal exercise capacity test, no road
cycling) and day 12 was a rest day. On the days of the max
tests the participants did not exercise for [16 h prior.
Participants completed the training on identical (size
adjusted) road racing bicycles (Orbea USA, North Little
Rock, AR) equipped with a power tap power meter integrated into the rear wheel (Powertap Pro 2.4 wireless, Saris
Cycling, Madison, WI). Ad libitum energy was provided in
the form of a hot breakfast and dinner that was well balanced and high in carbohydrate from a catering service that
specialized in bicycling tours. Dietary intake was not
recorded. However, participants were encouraged to

Eur J Appl Physiol (2012) 112:1621–1630

1623

Fig. 1 Schematic overview of
experimental testing associated
with 22 days of intensified
training

consume adequate calories and to stay hydrated. Due to the
fact that participants maintained body weight and body
composition, it can be assumed that energy balance and
hydration were maintained (Table 1). During the time
spent cycling, participants were provided with ad libitum
commercially available supplemental foods [energy bars
and sport drink (Gatorade, Chicago, IL)]. On day 2 and 22
(biopsy days), participants consumed the same amount and
form of energy with no consumption of calories in the last
hour of cycling before the muscle biopsy in order to control
for dietary influence of substrate use.

Substrate use

Body composition

Gross efficiency was calculated for each workload during
the VO2max tests until the respiratory exchange ratio
exceeded 1.00. The calculation was done in accordance
with the methodology demonstrated to be reliable by
(Moseley and Jeukendrup 2001).

Prior to any other physiological testing body density was
determined using hydrodensitometry and corrected for
estimated residual lung volume on days 1 and 21. Net
underwater weights were recorded using load cells (Exertech, Dresbach, MN). Body density was then converted to
body composition using the Siri equation (Siri 1993).
Maximal exercise capacity
Maximum oxygen consumption (VO2max) and power
associated with VO2max was measured for each subject
(Rest days 1 and 21) using a graded exercise protocol
(starting at 95 W and increasing 35 W every 3 min) on an
electronically braked cycle ergometer trainer (Computrainer, RacerMate Inc., Seattle, WA). Following an overnight
fast, participants rode to volitional fatigue (self-determined
by the subject as the point at which they could not continue) at a self-selected cadence. Maximum power was
calculated as the highest completed stage (in W) ? the
proportion of time in the last stage multiplied by the 35 W
stage increment. Expired gases were collected and averaged in 15 s intervals during the test using a calibrated
metabolic cart (Parvomedics, Inc., Salt Lake City, UT).

Table 1 Maximal aerobic capacity and body composition
VO2max
(L min-1)

Max watts

Weight
(kg)

Body fat
(%)

Day 1

4.49 ± 0.35

355 ± 38

72.2 ± 7.9

11.1 ± 3.3

Day 21

4.57 ± 0.58

365 ± 44

71.5 ± 7.1

9.9 ± 2.3

t test

p = 0.529

p = 0.275

p = 0.139

p = 0.071

Data are mean ± SD

Following an overnight fast ([10 h), expired steady-state
gas samples from the VO2max tests (last minute of each
stage when RER \1.0) on day 1 and day 21 (rest days)
were used to calculate whole-body carbohydrate and fat
oxidation using the equation of Péronnet and Massicotte
(Jeukendrup and Wallis 2005). Prior to this test, on both
days 1 and 21, subjects had not exercised for [16 h.
Gross efficiency

Biopsies
Biopsies were obtained pre and post exercise on days 2 and
22 for the analysis of muscle glycogen, metabolic enzymes
activity, metabolic gene expression, and genomic and
mitochondrial DNA copy number (see below). The pre
exercise biopsy was obtained approximately 10 min before
exercise and the post muscle biopsy was completed within
20 min after exercise. Biopsies were taken from the vastus
lateralis muscle using a 4–5 mm Bergstrom percutaneous
muscle biopsy needle with the aid of suction. Pre and post
biopsies were obtained from the same leg using a separate
incision 2 cm proximal to the previous biopsy. After excess
blood, connective tissue, and fat were removed, tissue
samples were immersed in liquid nitrogen and stored at
-80°C for later analysis.
Glycogen
Muscle glycogen was analyzed using an enzymatic spectrophotometric method. Samples were weighed upon removal
from a -80°C freezer and placed in 0.5 ml, 2 N HCl solution.
The sample solutions were weighed, incubated for 2 h at
100°C in an oven, then re-weighed and re-constituted to their
original weight using distilled water. To normalize pH, 1.5 ml
of 0.67 NaOH was added. A volume of this muscle extract
(100 ll) was added to 1 ml of Infinity glucose (HK) liquid
stable reagent (Thermo Fisher Scientific, Waltham, MA), and
read on a spectrophotometer at 340 nm. Muscle glycogen was
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Table 2 Primers and probes used for real-time PCR
Gene

Primer 1

Primer 2

Probe
CCAGGCCATCACTAAAGGCACCGA

B-globin

TGAAGGCTCATGGCAAGAAA

AAAGGTGCCCTTGAGGTTGTC

b-HAD

TGGCTTCCCGCCTTGTC

TTGAGCCGGTCCACTATCTTC

CGCCATACAGACCACAAAGCGGAA

COX

CTCTCCCCAGATGATGCCTTT

GGTCTCTTTGGGCGGAAGAC

CCCTGGATACTCTTACACAGCCGCCAA

CS

GACTACATCTGGAACACACTCCAACTCA

CGCGGATCAGTCTTCCTTAGTAC

ACGGGTTGTTCCAGGCTATGGCCA

GAPDH

GCTCTCTGCTCCTCCTGTTC

ACGACCAAACCGTTGACTC

ACATCAGCCGCATCTTCTT

MFN2

CCAGAGGGCAGAACTTTCTC

ATGCATCCCACTTAAGCAC

AGAGGCATCAGTGAGGTGCT

MtDNA

GCGGATGATTCAGCCATAATTTA

GACGCCTCAACCGCCTTT

CATCAATCGCCCACATCACTCGAGAC

PGC-1a

TGAGAGGGCCAAGCAAAG

ATAAATCACACGGCGCTCTT

AGAGGCAGAGGCAGAAGG

UCP3

TGACTCCGTCAAGCAGGTGTAC

CAAAATCCGGGTAGTGAGGCT

CCCCCAAAGGCGCGGACAAC

B-Globin beta globin, b-HAD beta-hydroxyacyl CoA dehydrogenase, COX cytochrome c oxidase subunit IV, CS citrate synthase, GAPDH Glyceraldehyde
3-phosphate dehydrogenase, MFN2 mitofusin 2, MtDNA mitochondrial DNA, PGC-1a peroxisome-proliferator-activated receptor-gamma co-activator 1
alpha, UCP3 uncoupling protein 3

then calculated using the extinction co-efficient of NADH.
Muscle glycogen concentrations are expressed in mmol kg-1
wet weight of muscle tissue.
Metabolic enzymes
Muscle (*10 mg) from pre exercise biopsies on day 2 and
22 were mechanically homogenized in CelLytic MT
mammalian tissue lysis/extraction reagent (Sigma #C3228,
Sigma Aldrich, St.Louis MO). For b-hydroxyacyl CoA
dehydrogenase (b-HAD), 20 ll of homogenate was added
to 970 ll of a reaction solution (6 ml 1 mM EDTA, 4 ml
1 M Imidazole (Sigma #68268), 3.5 ml 1 mM NADH
(Sigma #N4505-100 mg), and 86.5 ml distilled water) and
10 ll of 5 mM Acetylacetyl Co-A (Sigma #A1625). The
elimination of NADH was then followed for 90 s at
340 nm. Enzyme activity was calculated with the extinction co-efficient for NADH (6.22). Citrate synthase (CS)
was assayed using a citrate synthase assay kit (Sigma
#CS0720) according to the manufacturer’s specifications.
Cytochrome c oxidase (COX) was assayed using the
cytochrome c oxidase Assay Kit (CYTOCOX1, Sigma,
Saint Louis, Missouri) according to the manufacturer’s
protocol. All enzyme activities were measured at 25°C.
Skeletal muscle mRNA isolation
An 8–20 mg piece of skeletal muscle was homogenized
in 800 ll of trizol (Invitrogen, Carlsbad CA, Cat#
15596-018) using an electric homogenizer (Tissue Tearor,
Biosped Products Inc, Bartlesville OK). Samples were
then incubated at room temperature for 5 min after which
200 ll of chloroform per 1,000 ll of trizol was added and
shaken vigorously by hand. After an additional incubation
at room temperature for 2–3 min the samples were centrifuged at 12,000g for 15 min and the aqueous phase was
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transferred to a fresh tube. mRNA was precipitated by
adding 400 ll of isopropyl alcohol and incubated overnight at -20°C. The next morning samples were centrifuged at 12,000g for 10 min at 4°C and the mRNA was
washed by removing the supernatant and adding 800 ll of
75% ethanol. Samples were vortexed and centrifuged at
7,500g for 5 min at 4°C. mRNA was re-dissolved in
100 ll RNase-free water after the supernatant was
removed and the mRNA pellet was dried. The RNA was
cleaned using the RNeasy mini kit (Qiagen, Valencia CA,
Cat#74104) according to the manufacturer’s protocol
using the additional DNase digestion step (RNase-free
DNase set, Qiagen, Valencia CA, Cat# 79254). RNA
purity was analyzed by the A260:A280 ratio and amount
quantified on a nano-spectrophotometer (nano-drop ND1000, Wilmington DE).
cDNA synthesis
First-strand cDNA synthesis was achieved using Superscript-first-strand synthesis system for RT-PCR kit
(Invitrogen, Carlsbad CA, Cat #11904-0818) according to
the manufacturer’s protocol. Each sample (days 2 and 22
pre and post) within a given subject contained the same
amount of RNA (459 ± 27 ng). The resulting cDNA was
then diluted 29 using RNase-free water in order to have
adequate volume for RT-PCR and frozen for later
analysis.
Real-time RT-PCR
Primer and probe sequences are presented in Table 2.
Each 25 ll reaction volume contained 500 nM primers,
250 nM probe (PimeTime qPCR assay, Integrated DNA
technologies), 19 FastStart TaqMan Probe master (Roche
Applied Science, Indianapolis IN), and 2.5 ll of sample
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cDNA. PCR was then run using the Bio-Rad I Cycler iQ5
Real-Time PCR Detection system (Bio-Rad, Hercules
CA) using a 2-step Roche protocol (1 cycle at 50°C for
10 min, 1 cycle at 95°C for 10 min, followed by 40
cycles of 95°C for 15 s followed by 60°C for 1 min).
Quantification of mRNA was calculated using the 2-DCT
method as described by Livak and Schmittgen (2001) and
used in a similar context as the current investigation
(Dumke et al. 2009). Briefly, the 2-DCT method is the
difference or relative abundance of a gene of interest
versus the internal control or housekeeping gene and then
transformed (2-x) since CT data are logarithmic. This
method allows for the comparison of pre exercise values
on day 2 versus day 22 (in arbitrary units), whereas the
2-DDCT method does not. The 2-DDCT method would
yield relative fold change values of ‘‘1’’ for both day 2
pre and day 22 pre. GAPDH was used as the reference
housekeeping gene as it has been demonstrated to be the
most stable among other common housekeeping genes
with exercise (Jemiolo and Trappe 2004). In the current
study the stability of GAPDH was analyzed applying the
above-described 2-DCT method to pre exercise versus
post-exercise GAPDH. There was no difference in GAPDH with exercise (p = 0.498).
Mitochondrial DNA
DNA was extracted from skeletal muscle samples using
a QIamp DNA mini kit (Qiagen, Valencia CA, Cat#51304).
Relative copy number of mtDNA (nucleotides
14,918–14,986) per diploid nuclear DNA (b-Globin) was
determined based on the markers previously published
(Miller et al. 2003). The b-Globin gene was used as the
stable reference nuclear gene since it is a known single
copy gene that can act as a marker of diploid genome
content (Lawn et al. 1980). Sequences of probes and
primers are presented in Table 1. All samples were run in
duplicate. PCR for mtDNA and b-Globin were detected
using the procedures described above. The threshold cycle
number (CT) for mtDNA and b-Globin were used for the
calculation of relative copy number as previously described
(Szuhai et al. 2001).
Statistics
Differences in training parameters over the training period
were analyzed using paired t tests. Glycogen, mRNA, and
DNA ratio were compared over the training period and pre
to post exercise using two-way repeated-measures ANOVAs. Substrate utilization and gross efficiency were compared across graded exercise intensities and pre to post
training using repeated-measures ANOVAs. In the event of
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an ANOVA significant F ratio the Fisher’s Protected LSD
procedure was used to detect where differences occurred.
All ANOVAs were performed using SPSS for windows
Version 9 (Chicago, IL). A probability of type I error less
than 5% was considered significant (p \ 0.05). All data are
reported as mean ± SD.

Results
Training
During the intensified training period the participants
cycled 3,211 km (169 ± 13 km day-1 ? 1 rest day ? 2
max test days) over varied terrain. The riders averaged
167 ± 13 W for 281 min each training day. While the
average intensity remained low (47.2 ± 3.4% of pretraining maximum power), the daily mean time spent at an
intensity greater than 70% of maximum power output was
on average 71 min, of which 21 min were spent above
90%, during each day of riding. Average power output and
cycling time on day 2 and day 22 that were conducted on
the same terrain and distances were similar (187 ± 16 vs.
188 ± 22 W and 5.40 ± 0.44 vs. 5.55 ± 0.09 h, respectively), thus allowing reasonable comparison between the
two muscle biopsy days.
Maximal exercise capacity
Markers of fitness and performance including VO2max and
max power output during the VO2max test on days 1 and 21
did not change over the intensified training period
(Table 1). Additionally, body weight, and percent body fat
did not change (Table 1).
Substrate use
Regardless of day muscle glycogen decreased with exercise
(Day 2, 166 ± 44 mm kg-1 wet wt pre to 46 ± 6 mm
kg-1 wet wt post; Day 22, 197 ± 32 mm kg-1 wet wt
pre to 102 ± 38 mm kg-1 wet wt post (p = 0.002, main
effect of exercise) and was higher (p \ 0.001, main
effect of training) on day 22 versus day 2. There was a
trend (p = 0.09) for lower glycogen use on day 22 versus
day 2, which left 122% of day 2 glycogen available at
the end of exercise on day 22. Whole body fat oxidation
was elevated (p \ 0.05) at 165, 200, 235, and 270 W
(Fig. 2a) during the incremental exercise on day 21
compared with day 1. Whole body carbohydrate oxidation decreased with training (p \ 0.05) at all sub-maximal exercise intensities (Fig. 2b). Gross efficiency was
higher (p \ 0.05) at all sub-maximal exercise intensities
after training (Fig. 3).
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mRNA
Our housekeeping gene (GAPDH) did not change with
exercise or training (p [ 0.05, see ‘‘Materials and methods’’
for GAPDH stability information). PGC-1a expression
increased with acute exercise, but did not increase to the
same degree on day 22 as it did on day 2 (exercise 9 training interaction, Table 3). UCP3 did not
increase with acute exercise, but did decrease with 21 days
of training (Table 3). MFN2 increased with acute exercise
and responded the same on day 22 as it did on day 1
(Table 3). b-HAD mRNA and CS mRNA did not change
with acute exercise or with training (Table 3). COX mRNA
increased with acute exercise, but was unaffected with
training (Table 3).
Mitochondrial DNA content
The relative copy number of mtDNA per diploid nuclear
DNA did not increase with training, but did show a trend
toward an increase with acute exercise (p = 0.057,
Table 3).

Discussion
Fig. 2 Fat oxidation (a) and carbohydrate oxidation (b) during the
maximal aerobic capacity test on day 1 and day 21 of the intensified
training protocol. *p \ 0.05 from day 1 of the same intensity. Data
are mean ± SD

Fig. 3 Gross efficiency during the maximal aerobic capacity test on
day 1 and day 21 of the intensified training protocol. *p \ 0.05 from
day 1 of the same intensity. Data are mean ± SD

Metabolic enzymes
Mitochondrial maximal enzyme activities, from pre exercise samples, associated with beta-oxidation (b-HAD),
Krebs cycle (CS), and the electron transport chain (COX)
did not significantly change with training (Table 3).
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This investigation reports metabolic outcomes of an
intensified training program in already trained individuals.
The main finding was that despite robust changes in substrate use and cycling efficiency, markers of mitochondrial
development showed minimal adaptation in these trained
individuals. The modest changes in mitochondrial adaptation were despite a very aggressive endurance training
protocol that included cycling 3,211 km and two incremental maximal exercise tests over the course of 22 days.
This training protocol was very similar in terms of days and
riding time to the grand cycling tours. However, the participants in the current study were not capable of producing
the same power as elite riders (Lucia et al. 2003). The
current riders averaged 167 W throughout this training
period while grand tour riders have been reported to
average between 200 and 250 W on flat stages with an
even greater power output on mountain stages (Lucia et al.
2003).
The training-induced metabolic response is traditionally
explained by peripheral adaptations including increased
size and number of mitochondria. However, previous evidence suggests many training adaptations occur very early,
during which it is unlikely that mitochondrial protein
would have time to adapt. After just 3 days of training
muscle metabolites decrease, while glucose and lactate
transporters (Green et al. 2008a), Na? –K? -ATPase pumps
(Green et al. 2008b), and sarco-endoplasmic reticulum
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Table 3 Enzyme activity, mRNA (relative to GAPDH), and DNA pre and post exercise on day 2 and day 22 of intensified training
Day 2
Pre

Day 22
Post

Pre

Statistics
Post

Day
(main effect)

Pre-post
(main effect)

Day 2 post versus
Day 22 post
(interaction)

Enzyme activity
b-HAD
CS
COX

5.59 ± 0.87

5.36 ± 0.90

p = 0.397

31.69 ± 4.78

34.84 ± 3.33

p = 0.055

1.21 ± 0.39

1.76 ± 0.86

p = 0.126

mRNA
b-HAD

11.30 ± 4.33

CS

26.4 ± 7.67

COX

139 ± 47

10.27 ± 3.82

10.00 ± 3.25

p = 0.690

p = 0.253

25.83 ± 3.9

8.42 ± 2.63

29.24 ± 8.5

31.82 ± 7.47

p = 0.095

p = 0.630

231 ± 76*

157 ± 29

211 ± 57*

p = 0.971

p = 0.001

à

PGC-1a

2.86 ± 1.16

22.68 ± 9.62

2.87 ± 0.74

14.76 ± 6.30

p = 0.006

p \ 0.001

UCP3

4.84 ± 1.91

5.63 ± 2.60

3.06 ± 1.18

4.16 ± 1.91

p = 0.014

p = 0.131

MFN2

8.91 ± 4.96

12.56 ± 8.26*

7.51 ± 3.31

10.04 ± 4.19*

p = 0.361

p = 0.002

1,260 ± 467

921 ± 370

1,382 ± 639

p = 0.003

DNA
mtDNA/gDNA

1,028 ± 334

Data are mean 2-DCT ± SD
b-HAD Beta-hydroxyacyl CoA dehydrogenase, CS citrate synthase, COX cytochrome c oxidase, PGC-1a peroxisome-proliferator-activated
receptor-gamma co-activator 1 alpha, UCP3 uncoupling protein 3, MFN2 Mitofusin 2, mtDNA/gDNA relative copy number of mitochondrial
DNA (mtDNA) per diploid genomic nuclear DNA (gDNA)
* p \ 0.05 from pre (main effect)
à

p \ 0.05 from day 2 (main effect)
p \ 0.05 from day 2 Post (interaction)

Ca?? ATPase (SERCA) pumps (Duhamel et al. 2007)
increase. Following 5–12 days of training, a reduced reliance on muscle glycogen is observed (Phillips et al. 1996).
These adaptations occur without a parallel increase in
oxidative phosphorylation as measured by maximal
enzyme maximal activity. In the current study, substrate
use was altered while mitochondrial enzyme maximal
activities, VO2max, and maximum power output were not.
These observations support the notion that metabolic shifts
may happen independently of mitochondrial capacity
alterations, as has been previously reported in untrained
individuals (Phillips et al. 1996). From the current data it
cannot be determined if the observed shifts in substrate use
reflect a chronic training adaptation or the rise in fat oxidation that continues for days after an acute exercise bout
(Henderson et al. 2007). However, substrate use was
determined in the current study following an overnight fast,
and more than 16 h after their last bout of exercise. This
would likely lessen, but not completely account for the
acute effects on substrate use. In addition, subjects were
engaged in normal training prior to the pre substrate use
determination although not to the same magnitude as the
post. Both possibilities (acute or chronic effect of training
on substrate use) provide evidence of the observed disconnect between mitochondrial adaptations and substrate
use.

While a change in the maximal activities of these
enzymes would imply a change in protein content, there is
the possibility that these enzymes do not fully represent the
complexity of mitochondrial morphology. To address this
concern, we have included measures of additional mRNA
and DNA. These measures address other possible changes
within the mitochondria and ultimately the oxidative
potential of the muscle. In general, the mRNA for the
measured enzymes followed the same pattern as the maximal enzyme activities. However, COX mRNA showed no
difference with training, but did increase with acute exercise further highlighting the complexity of the mechanisms
involved and indicate elevated mitochondrial turnover after
acute endurance exercise.
Mitochondrial uncoupling protein 3 (UCP3) is highly
expressed in skeletal muscle, and despite a considerable
amount of investigation the role of UCP3 is yet to be
conclusively determined. UCP3 mRNA is typically
increased with acute exercise (Schrauwen et al. 2002) and
decreased with endurance training (Schrauwen et al. 2005).
It has also been suggested that the acute response may be
different between trained and untrained individuals (Schmutz et al. 2006) although the current data do not statistically support an altered UCP3 response with training. The
current UCP3 mRNA data did not increase with acute
exercise, but did demonstrate a reduction with training. The
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impact these changes have on the mitochondria and whole
body substrate use is unclear. Over-expression of UCP3 in
mouse skeletal muscle has been shown to increase fatty
acid oxidation (Wang et al. 2003). Therefore, it is possible
that UCP3 expression may promote an increase in fatty
acid oxidation during acute exercise. However, this
explanation does not provide a model for reduced UCP3
and increased fatty acid oxidation following training.
Alternatively, the reduced levels of UCP3 after training
may be a factor related to reactive oxygen species (ROS)
mitigation or fatty acid anion export (Bezaire et al. 2007).
From measures in this study, the oxidative capacity of
muscle seems to be unchanged. Thus, it is unlikely that
UCP3 is lowered due to an increased mitochondrial
capacity to withstand fatty acid flux and less of a need for
UCP3 mediated export of fatty acid anions from the
mitochondria as put forth in the model by Himms-Hagen
and Harper (2001). Clearly, more research is needed to
understand the mechanism associated with UCP3 alterations with exercise and training.
The transcriptional co-activator protein PGC-1a is
induced in human skeletal muscle by exercise and mediates
many of the adaptations to exercise (Pilegaard et al. 2003).
Transgenically over-expressed PGC-1a in mice induces
mitochondrial biogenesis and yields muscle with an
increased oxidative capacity (Wende et al. 2007). PGC-1a
is required for expression of many mitochondrial genes (Lin
et al. 2004) and the loss of PGC-1a leads to exercise
intolerance and significant deficiencies in oxidative
metabolism. Thus, PGC1a is an important regulator of
mitochondrial biogenesis and as such is an attractive marker
of mitochondrial development potential. The current protocol yielded a large increase in PGC1a mRNA with
exercise on day 2. However, the increase on day 22 was
smaller than that on day 2, despite the same amount of work
performed on those 2 days (180 ± 16 and 188 ± 21 average watts over the same course; p [ 0.05). Whether this is
related to less reliance on muscle glycogen and subsequent
AMPK activity (Wojtaszewski et al. 2003), or an attenuated
hormonal response is beyond the scope of our data. Previous research evaluating PGC-1a response with training has
ranged from no difference in response to exercise before
and after 9 days of training (Tunstall et al. 2002) to an
increased PGC- 1a response after 4 weeks of training
(Pilegaard et al. 2003). The exact reason for conflicting
results between studies is not evident. However, these
projects differed in subject fitness, training duration, training intensity, mode of exercise, and muscle sampling time
making direct comparisons difficult. Specifically, the previous investigations (Pilegaard et al. 2003; Tunstall et al.
2002) were conducted using untrained participants, a much
shorter exercise duration (*1 h), and a higher average
exercise intensity (63–70% of VO2max) than the current
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study. The exact impact that these factors have on the
results is unknown. However, the current study provides
good external validity to endurance athletes who do train
with high volumes and low average intensity. It should be
pointed out that while the current average intensity was low,
the participants spent an average of 71 min each cycling
day at intensities greater than 70%. Therefore, intensity may
not be the key factor in these differing results.
Recent interest in mitochondrial function has suggested
that mitochondria undergo constant fusion and fission (Liu
et al. 2009). The current data demonstrate that MFN2 mRNA
increases acutely following a *5 h bout of cycling exercise,
but not over 21 days of training. This is supportive of the role
of MFN2 enhancing mitochondrial metabolism (Bach et al.
2003). The present study also shows a trend toward acute
increases in mtDNA/gDNA ratios, but no change with
training. Previous evidence in the literature has suggested
that the mtDNA/gDNA ratio is an indicator of mitochondrial
capacity (Menshikova et al. 2007). It is important to point out
that these studies used subjects undergoing an exercise
intervention with the goals of weight loss (Menshikova et al.
2007). Studies in previously trained humans were not able to
demonstrate an increase in this mitochondrial marker (Yeo
et al. 2008) while another study reports a decrease with acute
fatiguing exercise (Marcuello et al. 2005). Conflicting results
may be due to the variability in this marker. It is unclear
whether this variability is methodological, a function of
mixed fiber sampling, fiber recruitment, exercise duration
and intensity, or perhaps as we propose here, a complex
fusion/fission interaction as the result of exercise. Exercise
has been shown to increase mitochondrial fusion (Cartoni
et al. 2005), but it is unclear as to the fate of the relative
mtDNA copy number during the fusion events. It has been
suggested that fusion results in mtDNA recombination (Ono
et al. 2001); however, direct evidence of this recombination
does not yet exist. The rates of fusion and fission also affect
mitochondrial function, with fusion resulting in greater
oxidative capacity potential due to matrix content mixing but
perhaps independent of enhanced expression of oxidative
enzymes (Liu et al. 2009). This model is one possibility to
explain the whole body oxidation changes we have seen here
without apparent increases in oxidative enzyme activities.
Some concessions in study design were needed in order to
accommodate the high volume training in a field environment. The current data should be interpreted in the context of
the field approach taken in this study. While diet was controlled during pre and post substrate use measurements, diet
was not controlled for throughout the 21 day training period.
Participants were allowed daily ad libitum energy consumption from variable sources during the training period.
Additionally, these participants entered the study in a trained
state, which may have limited the potential for mitochondrial
adaptation and makes comparison to research using

Eur J Appl Physiol (2012) 112:1621–1630

untrained subjects difficult. Furthermore, biopsy timing may
not have been ideal for the detection of gene expression as
many of these genes could have a longer time course of
activation or may reflect activation from subsequent days of
exercise; however, the timing was identical on both days.
Each day that biopsies were performed (for gene expression
experiments) was preceded by a relatively light day which
included only a graded exercise test (Fig. 1). To our
knowledge there are no studies in the literature that have
considered mRNA expression following a 5–6 h exercise
protocol over 21 days of training. It should be noted that
biopsies were obtained 5–6 h after the initiation of exercise
on both day 2 and day 22. While the current approach to
mitochondrial function measurement was multi-factorial,
additional measures addressing mitochondrial fission and
mitochondrial oxygen flux may add more clarity as to the
mechanisms associated with training-induced mitochondrial
adaptations in already trained individuals. Further work
addressing these limitations is needed to elucidate the
mechanism behind this cascade of events.
In summary, the current data suggest that the whole
body oxidation changes observed with training cannot be
solely explained by mitochondrial development and that a
disconnect between whole body substrate use and mitochondrial development may exist. Mitochondrial development is a crucial adaptation to endurance training.
However, other adaptations may contribute to metabolic
changes when already trained individuals initiate a period
of intensified training. Furthermore, mitochondrial adaptations during training may involve more complex fission/
fusion dynamics then classical methods can detect.
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